Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof

Details for Australian Patent Application No. 2010314593 (hide)

Owner Sichuan Beilike Biotechnology Limited Liability Company

Inventors Que, Feng; Wang, Ying

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010314593

PCT Pub. Number WO2011/054292

Priority 61/257,924 04.11.09 US

Filing date 3 November 2010

Wipo publication date 12 May 2011

International Classifications

C07D 263/22 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/054292 Priority application(s): WO2011/054292

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314602-Use of danshensu, notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder

2010314582-Method, system and network equipment for implementing HTTP-based streaming media service